NASDAQ
CanSino Biologics Inc. (CASBF) has a free cash flow growth of -1198.18% as of Friday, May 29, 2026. This represents a 1306.78% decrease compared to its 12-month average of -85.17%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.